1. Anon. n.d.-a. Clinical Experience With Timolol in Childhood Glaucoma|JAMA Ophthalmology|JAMA Network. [cited 2021 Sep 26]. https://jamanetwork.com/journals/jamaophthalmology/article-abstract/635643.
2. Anon. n.d.-b. A randomized trial assessing Dorzolamide in patients with glaucoma who are younger than 6 years|Glaucoma|JAMA Ophthalmology|JAMA Network. [cited 2021 Sep 26]. https://jamanetwork.com/journals/jamaophthalmology/article-abstract/417240.
3. Anon. n.d.-c. Indications for surgical management of hyphema in patients with sickle cell trait. JAMA Ophthalmol. JAMA Network. [cited 2021 Sep 26]. https://jamanetwork.com/journals/jamaophthalmology/article-abstract/635018.
4. Black AC, Jones S, Yanovitch TL, Enyedi LB, Stinnett SS, Freedman SF. Latanoprost in pediatric glaucoma—pediatric exposure over a decade. J AAPOS. 2009;13(6):558–62.
5. Boger WP, Walton DS. Timolol in uncontrolled childhood Glaucomas. Ophthalmology. 1981;88(3):253–8.